Technology Archives - Page 2 of 21 - Boston Life Sciences Times

Obsidian Therapeutics Completes Galera Merger and $350 Million Financing

August 3, 2026

Sail Biomedicines, Johnson & Johnson Partner on In Vivo CAR-T Therapies

July 30, 2026

Synlogic, Caldera Therapeutics Agree to Merge in All-Stock Deal

July 29, 2026

THIS WEEK'S STORIES

Epredia Adds Automated Pathology Sample Archiving Systems to U.S. Portfolio

July 28, 2026

Iksuda Receives FDA IND Clearance for IKS04 in Gastrointestinal Cancers

July 30, 2026

QT Imaging Appoints Julia Albright, Ph.D., as Chief Science Officer

July 29, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Technology

Insilico Medicine Launches AI Benchmark for Drug Discovery Models

Wolters Kluwer, Epic Expand Clinical Information Access for Rural and Underserved Providers

Norway Renews Nationwide Use of Wolters Kluwer’s UpToDate Platform

AcuityMD Surpasses 500 Medical Device Customers as MedTech AI Adoption Grows

Seek Labs Publishes Study Validating Room-Temperature Molecular Diagnostic Technology

Most Read

CREATE Medicines Cleared to Begin Phase 1/2 Trial of In Vivo CAR-T Therapy for Autoimmune Diseases

Insilico Medicine Launches AI Benchmark for Drug Discovery Models

Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million

Decoy Therapeutics Expands Patent Portfolio for Antiviral Platform

EDITOR PICKS